The Sage Group Expands Team in North America – Dr. Christine T. Fischette Joins as New Executive Dir

London, England and New York, February 17 2020 - The Sage Group Inc. today announced that Dr. Christine T. Fischette will join the firm as an Executive Director. “We are delighted that Chris has decided to join Sage. Chris will bring her wide-ranging expertise with healthcare and bioscience clients to The Sage Group. Chris has a prestigious career in the pharma industry, ranging from startups to large corporate entities, and this will complement our existing skill set at Sage Healthcare.” said Wayne Pambianchi, Executive Director of The Sage Group. “Chris brings both a strong scientific background in pharma as well as extensive corporate and deal-making experience.”

Chris received her Ph.D. in Physiology from Rutgers Biomedical Health Sciences.

Since 2010 Chris is the Founder & CEO of BioLinkUp LLC, a Corporate Strategy/Business Development entity, where she specializes in advising companies on growth strategies, business development, partnering / licensing and drug development.

<